WILLIAM RASBERRY: Open Payments
NPI 1891020129 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 8 payments from 5 companies in 2025. Trend: 2023 $132 · 2024 $162 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Alkermes, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: BRIXADI, CAPLYTA, VIVITROL, Auvelity, FANAPT.
Industry payments across LA — which companies pay providers there.
